[144] Ceragon Networks Ltd SEC Filing

Rhea-AI Filing Summary

Ceragon Networks Ltd (CRNT) filed a Form 144 reporting a proposed sale of 14,183 ordinary shares through Oppenheimer & Co. on NASDAQ with an aggregate market value of $26,096.72. The filing lists 88,392,925 shares outstanding, so the proposed sale is a very small fraction of the company.

The securities being sold were acquired as restricted stock units (RSUs) granted on 08/01/2022 (30,060), 08/08/2023 (5,415) and 08/05/2024 (1,455). The notice indicates no securities sold in the past three months, and includes the signer’s attestation they are not aware of undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: The planned sale is immaterial in size relative to outstanding shares and unlikely to move markets.

The filing discloses a proposed sale of 14,183 ordinary shares with an aggregate value of $26,096.72, executed via Oppenheimer on NASDAQ. Against the reported 88,392,925 shares outstanding, this represents a negligible portion of the capital base. The shares were acquired via RSU grants in 2022–2024, which is consistent with routine executive compensation monetization. No sales were reported in the prior three months. Overall, this is a standard Rule 144 notice without clear market-moving implications.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 procedures; the filer affirms no undisclosed material adverse information.

The Form 144 provides required details: class of security, broker, acquisition history, and outstanding shares. The seller’s representation that they do not possess undisclosed material adverse information is explicitly stated in the remarks. The RSU origin of the shares and the absence of recent sales suggest routine compliance and monetization of compensation rather than signaling governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	14183	26096.72	88392925	08/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/01/2022	Restricted Stock Units	From the Issuer			30060	08/01/2022	N/A
Ordinary	08/05/2024	Restricted Stock Units	From the Issuer			1455	08/05/2024	N/A
Ordinary	08/08/2023	Restricted Stock Units	From the Issuer			5415	08/08/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Ceragon Networks (CRNT) report in the Form 144?

The company filed a Form 144 reporting a proposed sale of 14,183 ordinary shares with an aggregate market value of $26,096.72 on NASDAQ via Oppenheimer & Co.

How were the shares being sold originally acquired?

The securities were acquired as Restricted Stock Units (RSUs) on 08/01/2022 (30,060), 08/08/2023 (5,415), and 08/05/2024 (1,455).

Does the filing report any securities sold in the past three months?

No. The Form 144 indicates "Nothing to Report" for securities sold during the past three months.

Which broker will execute the sale and what is the approximate sale date?

The broker listed is Oppenheimer & Co. Inc., 85 Broad St. New York NY 10004, and the approximate date of sale is 08/08/2025.

How large is the proposed sale relative to outstanding shares?

The filing shows 14,183 shares to be sold out of 88,392,925 outstanding shares, with an aggregate value of $26,096.72.